terazosin

Generic: terazosin

Labeler: remedyrepack inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin
Labeler remedyrepack inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
REMEDYREPACK INC.

Identifiers & Regulatory

Product NDC 70518-4545
Product ID 70518-4545_4858e58c-659f-f2d0-e063-6294a90aebaf
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075667
Listing Expiration 2027-12-31
Marketing Start 2026-01-13

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705184545
Hyphenated Format 70518-4545

Supplemental Identifiers

RxCUI
313217
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin (source: ndc)
Application Number ANDA075667 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BLISTER PACK (70518-4545-0)
source: ndc

Packages (1)

70518-4545-0 30 CAPSULE in 1 BLISTER PACK (70518-4545-0)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4858e58c-659f-f2d0-e063-6294a90aebaf", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["a16abe41-98e7-4e60-8c1b-911c6a29f0a2"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BLISTER PACK (70518-4545-0)", "package_ndc": "70518-4545-0", "marketing_start_date": "20260113"}], "brand_name": "Terazosin", "product_id": "70518-4545_4858e58c-659f-f2d0-e063-6294a90aebaf", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "70518-4545", "generic_name": "Terazosin", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075667", "marketing_category": "ANDA", "marketing_start_date": "20260113", "listing_expiration_date": "20271231"}